Hasil Pencarian - G. Basile
- Menampilkan 1 - 20 hasil dari 21
- Ke Halaman Berikutnya
-
1
-
2
-
3
-
4
1340 NDI-101150 is a potent and highly selective hematopoietic progenitor kinase 1 (HPK1) inhibitor that promotes a robust and broad anti-tumor immune response oleh Scott Daigle, David Ciccone, Samantha Carreiro, Christine Loh, Neelu Kaila, Fu-Shan Kuo, Scott Boiko, Gene Yau, Esha A Gangolli, Denise Levasseur, Bhaskar Srivastava, Frank G Basile
Diterbitkan 2023-11-01Artikel -
5
The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy oleh A. Larcher, G. Fallara, G. Rosiello, G. Basile, C. Re, G. Baiamonte, S. Agnesi, D. Cignoli, G. Colandrea, A. Briganti, R. Bertini, A. Salonia, F. Montorsi, U. Capitanio
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
6
Emerging diabetes therapies: Bringing back the β-cells oleh G. Basile, M.M.F. Qadir, F. Mauvais-Jarvis, A. Vetere, V. Shoba, A.E. Modell, R.L. Pastori, H.A. Russ, B.K. Wagner, J. Dominguez-Bendala
Diterbitkan 2022-06-01Dapatkan teks lengkap
Artikel -
7
PB2099: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-1607, A FIRST-IN-CLASS ORAL CBL-B INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES INCLUDING RICHTER TRANSFORMATION DLBCL oleh A. Sharp, A. Williams, S. Blagden, R. Plummer, D. Hochhauser, M. G. Krebs, S. Pacey, J. Evans, S. Whelan, S. Nandakumar, S. Rogers, K. L. Jameson, F. G. Basile, J. de Bono, H.-T. Arkenau
Diterbitkan 2022-06-01Dapatkan teks lengkap
Artikel -
8
Pathological features and predictors of oncologic outcomes in patients with small renal masses oleh R. Bertini, G. Rosiello, F. Muttin, G. Baiamonte, C. Re, S. Agnesi, C. Bravi, M. Bandini, G. Basile, D. Cignoli, A. Briganti, A. Salonia, F. Montorsi, U. Capitanio, A. Larcher
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
9
751 Monotherapy results from an ongoing phase 1a dose escalation study of NDI-101150, a highly selective oral hematopoietic progenitor kinase 1 (HPK1) inhibitor oleh Scott Daigle, Sunil Sharma, Xinyan Zhang, Martin Gutierrez, Patricia Fraser, David Sommerhalder, Scott Boiko, Esha A Gangolli, Bhaskar Srivastava, Frank G Basile, Marcus Noel, Amanda Hoerres, Nawaid Rana, Rama Balaraman
Diterbitkan 2023-11-01Artikel -
10
Incongruence between turb and radical cystectomy findings in terms of histological variant identification: analysis of all potential clinical risk factors oleh A. Gallina, E. Zaffuto, S. Scuderi, G. Basile, A. Salonia, R. Lucianò, F. Pederzoli, G. Burgio, M. Moschini, V. Scattoni, F. Dehò, A. Briganti, F. Montorsi, R. Colombo, A. Necchi, M. Bandini
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
11
Trifecta outcomes after percutaneous renal mass ablation: a multicenters analysis oleh F. Crocerossa, U. Carbonara, A. Larcher, G. Basile, R. Damiano, F. Cantiello, U.G. Falagario, A. Veccia, P. Ditonno, M. Battaglia, V. Mirono, I. Derweesh, F. Montorsi, U. Capitanio, R. Autorino
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
12
Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function oleh G. Fallara, A. Larcher, G. Rosiello, G. Basile, D. Cignoli, G. Colandrea, A. Martini, W. Cazzaniga, C.A. Bravi, M. Bandini, G. Baiamonte, A. Briganti, A. Salonia, R. Bertini, F. Montorsi, U. Capitanio
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
13
Impact of histological variants in node positive patients treated with radical cystectomy for bladder cancer oleh M. Bandini, E. Zaffuto, S. Scuderi, G. Basile, A. Salonia, R. Lucianò, F. Pederzoli, S. Zamboni, L. Afferi, B. Giusy, M. Moschini, F. Dehò, R. Bertini, A. Briganti, F. Montorsi, R. Colombo, A. Necchi, A. Gallina
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
14
No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from t... oleh G. Basile, M. Bandini, E. Zaffuto, S. Scuderi, F. Pederzoli, L. Marandino, D. Raggi, F. Barletta, G. Gandaglia, N. Fossati, G. Burgio, M. Moschini, S. Zamboni, L. Afferi, S. Comana, A. Briganti, F. Montorsi, R. Colombo, A. Necchi, A. Gallina
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
15
Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial? oleh G. Basile, M. Bandini, E. Zaffuto, S. Scuderi, F. Dehò, A. Salonia, R. Matloob, G. Burgio, L. Sciacqua, R. Bertini, S. Comana, M. Moschini, S. Zamboni, L. Afferi, V. Scattoni, R. Colombo, A. Briganti, F. Montorsi, A. Necchi, A. Gallina
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
16
Association between BRCA 1/2 polymorphisms and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy oleh V. Cucchiara, D. Lazarevic, D. Cittaro, M. Zoccolillo, M. Bianchi, N. Longo, S. Scuderi, F. Barletta, A. Martini, E. Mazzone, G. Basile, G.O. Cirulli, D. Cignoli, M. Tutolo, N. Fossati, G. Gandaglia, V. Mirone, F. Montorsi, G. Tonon, A. Briganti
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
17
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial oleh B. Marco, A. Martini, J. Pfail, G. Gandaglia, N. Fossati, S. Scuderi, G. Fallara, F. Barletta, D. Robesti, A. Rizzo, G. Basile, C.A. Bravi, G. Rosiello, L. Nocera, A. Stabile, A. Gallina, A. Salonia, F. Montorsi, A. Briganti, M.D. Galsky, W.K. Oh
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
18
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database oleh G. Sorce, A. Martini, J. Pfail, U.G. Falgario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, D. Cignoli, G. Basile, L. Nocera, G. Rosiello, E. Mazzone, C.A. Bravi, A. Necchi, F. Montorsi, A. Briganti, M.D. Galsky, J.P. Sfakianos
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
19
Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches oleh F. Barletta, A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, G.O. Cirulli, G. Basile, V. Cucchiara, D. Robesti, M. Menean, G. Rosiello, C.A. Bravi, P. Dell’Oglio, A. Martini, A. Salonia, L. Sciacqua, G. Brembilla, A. Esposito, F. Montorsi, F. De Cobelli, A. Briganti
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
20
Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data oleh A. Martini, A.B. Parikh, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, R. Leni, V. Cucchiara, C.A. Bravi, E. Mazzone, G. Rosiello, G. Basile, L. Nocera, A. Necchi, M. Moschini, J.P. Sfakianos, M.D. Galsky, W.K. Oh, C. Tsao, F. Montorsi, A. Briganti
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel